Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
1-Acetyl-2-imidazolidinone is identified as a drug impurity associated with clonidine. This compound serves as a valuable reference standard in the analysis and characterization of pharmaceutical formulations. Its role in ensuring the quality and safety of drug products makes it indispensable for research applications focused on impurity profiling and regulatory compliance. -
Drug Impurity
Flecainide Impurity 1, also known as 2-Aminomethylpiperidine, is a chemical impurity associated with the antiarrhythmic agent Flecainide. This compound is primarily utilized in quality control processes and method development within pharmaceutical research. Its characterization is crucial for ensuring the purity and stability of Flecainide formulations, thereby supporting the development of effective cardiac treatments. -
Drug Impurity
Rivaroxaban impurity 68 is a known impurity associated with the anticoagulant Rivaroxaban, primarily affecting its pharmacological profile. This compound is utilized for analytical and quality control purposes in pharmaceutical research and development, particularly in assessing the purity of Rivaroxaban formulations. Its characterization is essential for ensuring compliance with regulatory standards in drug manufacturing and development processes. -
Drug Impurity
Iluoridine Impurity 9 is a known impurity of Iluoridine, a nucleoside analogue. This compound is important for research applications focusing on the purification and characterization of drug substances. Its assessment can aid in understanding the quality and safety profiles of nucleoside-based therapeutics. -
Drug Impurity
Glycopyrronium impurity 3 is an identified impurity of the pharmaceutical compound Glycopyrronium, which acts as a competitive antagonist of muscarinic receptors. This impurity is significant for analytical and quality control studies in drug development, addressing safety and efficacy concerns. Its presence and concentration can impact the overall stability and purity of Glycopyrronium formulations, making it essential for pharmacological research and regulatory compliance. -
Drug Impurity
Montelukast impurity 10 is a chemical impurity related to Montelukast, a leukotriene receptor antagonist. It serves as a reference standard in pharmaceutical research for assessing the purity of Montelukast formulations. Its analysis is critical for ensuring compliance with regulatory standards and enhancing the quality control processes in drug development. -
Drug Impurity
Nimesulide impurity 4, also known as Aminodiphenylether, is a chemical impurity associated with the analgesic and anti-inflammatory drug Nimesulide. This compound is important for assessing the quality and safety of pharmaceutical formulations in drug development and regulatory compliance. It serves as a reference standard for analytical methods aimed at identifying and quantifying impurities in Nimesulide products. -
Drug Impurity
Apixaban impurity 20 is a chemical impurity associated with the anticoagulant drug Apixaban. Its characterization is crucial for ensuring the purity and safety of Apixaban formulations. This impurity can serve as a reference standard in analytical chemistry, facilitating research and quality control in pharmaceutical development and regulatory compliance. -
Drug Impurity
Ibrutinib Impurity 28 is an impurity associated with Ibrutinib, a selective inhibitor targeting Bruton's tyrosine kinase (BTK). This compound is essential for analytical and quality control applications in pharmaceutical research, aiding in the characterization and assessment of Ibrutinib formulations. The study of impurities such as Ibrutinib Impurity 28 is crucial for ensuring the purity and efficacy of pharmaceutical products. -
Drug Impurity
Montelukast impurity 3 is a detectable impurity associated with the asthma medication Montelukast, a leukotriene receptor antagonist. This compound is important for analytical chemistry studies, specifically in evaluating the purity and stability of Montelukast formulations. Researchers utilize this impurity to assess quality control metrics and ensure compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Amoxicillin Impurity 7 is a known impurity of the antibiotic compound Amoxicillin, primarily serving as a reference standard in analytical chemistry. This compound is crucial for the assessment of drug purity and quality control in pharmaceutical research. Its characterization aids in understanding the stability and degradation pathways of Amoxicillin, facilitating compliance with regulatory requirements in drug formulation and development. -
Drug Impurity
Aripiprazole impurity 23 is a recognized impurity associated with the antipsychotic compound Aripiprazole. This impurity is critical for quality control and analytical studies in pharmaceutical research, allowing for the assessment of drug purity and stability. Its identification and quantification are important for ensuring compliance with regulatory standards and understanding the drug’s profile in formulations. -
Drug Impurity
Lamivudine impurity 4 is a drug impurity associated with Lamivudine, an antiretroviral medication. This compound is relevant for analytical studies and quality control processes in pharmaceutical research, particularly for ensuring the purity and safety of Lamivudine formulations. Its identification and quantification can aid in understanding process-related impurities that may affect drug efficacy and patient safety. -
Drug Impurity
Bupropion impurity 13 is identified as a drug impurity associated with bupropion. It serves as a critical compound for analytical chemistry studies and quality control in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of bupropion formulations, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Neratinib impurity 11 is a drug impurity associated with Neratinib, a potent irreversible inhibitor of the human epidermal growth factor receptor 2 (HER2). This impurity may be utilized in the characterization and quality control of Neratinib during pharmaceutical development. Its detailed analysis is essential for ensuring the integrity and safety of HER2-targeted therapies. -
Drug Impurity
Lidocaine impurity 12 is a known impurity of the local anesthetic Lidocaine, which primarily acts as a sodium channel blocker. This compound is valuable for research involving drug formulation and stability studies, as it aids in understanding the impact of impurities on pharmacological profiles. Its characterization is essential for ensuring the quality and safety of Lidocaine-containing formulations. -
Drug Impurity
Pitavastatin impurity 12 is a known impurity of Pitavastatin, a statin used for cholesterol management. This compound serves as a critical analytical standard for the assessment of purity in drug formulation and research. Its identification and quantification are essential for ensuring the quality and safety of statin-based therapies in pharmaceutical development. -
Drug Impurity
Valproic acid impurity 1 is a known impurity associated with Valproic acid, primarily functioning as a drug impurity. It is relevant in the study of pharmaceutical formulations and drug purity analysis, serving as a standard reference for quality control and regulatory compliance in the development of Valproic acid-containing medications. This compound is essential for understanding the implications of drug impurities on therapeutic efficacy and safety. -
Drug Impurity
Ticagrelor impurity 27 is a chemical impurity derived from the antiplatelet agent Ticagrelor. This reagent is essential for impurity profiling and quality assurance in the synthesis of Ticagrelor. Its characterization is crucial for regulatory compliance and ensuring the safety and efficacy of pharmaceutical formulations. Researchers can utilize this impurity to study the metabolic pathways and potential effects related to Ticagrelor administration. -
Drug Impurity
Rotigotine impurity 2 is a chemical impurity associated with Rotigotine, a dopaminergic anti-Parkinson agent. As a drug impurity, it is essential for quality control and analytical research in pharmaceutical development. Understanding and characterizing this impurity can aid in assessing the safety, efficacy, and stability of Rotigotine formulations in drug development processes. -
Drug Impurity
Vonoprazan impurity 46 is a known impurity of the proton pump inhibitor Vonoprazan, which acts by inhibiting the H+/K+ ATPase in gastric parietal cells. This impurity is vital for quality control during the synthesis of Vonoprazan, aiding in the identification and characterization of the compound. Its analysis is essential for ensuring the purity and efficacy of formulations containing Vonoprazan in pharmaceutical research. -
Drug Impurity
Rosuvastatin impurity 47 is a specific impurity identified in the synthesis of Rosuvastatin. This compound serves as a crucial reference standard for the quality control and analysis of Rosuvastatin formulations. Its characterization is vital for ensuring compliance with pharmaceutical regulations and for understanding the compound's overall purity and stability in drug development applications. -
Drug Impurity
Indobufen impurity 2 is a known impurity of the pharmaceutical compound Indobufen. It is utilized primarily in analytical chemistry and pharmaceutical development to assess the purity of Indobufen formulations. This impurity may play a role in understanding the compound's stability and potential side effects in drug formulation and safety assessments. -
Drug Impurity
Palbociclib impurity 2 is a known chemical impurity associated with Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. This compound is critical in quality control and analytical studies related to Palbociclib synthesis, providing insight into the stability and purity of the final product. Research applications include assessing drug safety and efficacy, as well as developing purification methodologies in pharmaceutical development. -
Drug Impurity
Clopidogrel impurity 1 is a known impurity of the antiplatelet agent Clopidogrel, primarily serving as a marker for quality control in pharmaceutical formulations. This compound is critical for analytical studies, enabling researchers to assess the purity and stability of Clopidogrel formulations. Its detection is essential for ensuring compliance with regulatory standards in drug development and safety evaluations. -
Drug Impurity
Naproxen impurity 1 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Naproxen. It is relevant in pharmacokinetic studies, quality control processes, and stability testing of pharmaceutical formulations. This compound is essential for understanding the safety and efficacy profiles of Naproxen and its related formulations. Researchers may utilize this impurity to investigate potential side effects and ensure regulatory compliance in drug development. -
Drug Impurity
Edoxaban impurity 1 is a byproduct associated with Edoxaban, an anticoagulant medication targeting factor Xa. This impurity is relevant for analytical chemistry and quality control studies, where it serves as a reference standard for the identification and quantification of impurities in drug formulations. Its presence in stability studies is critical for ensuring the purity and efficacy of Edoxaban in pharmaceutical applications. -
Bupivacaine Impurity
2,6-Dichlorocapronic acid xylidide is an impurity associated with Bupivacaine, a commonly used local anesthetic. This compound’s presence may impact the purity and efficacy of Bupivacaine formulations. It serves as an important reference for analytical studies and quality control in pharmaceutical research related to local anesthetics. -
Drug Impurity
Gabapentin acid impurity 1, an impurity of Gabapentin acid, is primarily utilized as a reference standard in analytical chemistry. Its characterization is crucial for ensuring the quality and consistency of gabapentin formulations. This compound serves an important role in research applications focused on the determination of drug purity and assessment of pharmacological profiles. -
Drug Impurity
Clevidipine butyrate impurity 1 is a known impurity of Clevidipine butyrate, which is a calcium channel blocker used in the management of hypertension. This compound serves as a reference standard for analytical tests and quality control assessments in pharmaceutical development. Researchers can utilize this impurity to ensure the purity and safety of drug formulations containing Clevidipine butyrate. -
Drug Impurity
rel-Bedaquiline is a known impurity of the anti-tuberculosis drug bedaquiline. It may exhibit biological activity relevant to the evaluation of drug safety and efficacy in tuberculosis research. This compound is essential for analytical studies focusing on drug purity and the comprehensive assessment of pharmaceutical formulations. -
Drug Impurity
Bazedoxifene impurity 2 is a byproduct of Bazedoxifene, which targets estrogen receptors. This compound is critical in assessing drug purity and stability, as well as understanding the safety and efficacy profiles of Bazedoxifene. It is relevant in pharmaceutical research focusing on selective estrogen receptor modulators (SERMs) and their associated properties. -
Drug Impurity
Ticagrelor impurity 8 is a chemical impurity associated with the antiplatelet agent Ticagrelor. This impurity is essential for assessing the purity and stability of Ticagrelor formulations in pharmaceutical research. It plays a crucial role in ensuring the safety and efficacy of drug products and is relevant in synthetic and analytical chemistry applications related to cardiovascular studies. -
Drug Impurity
Metoprolol impurity 3 hydrochloride is a chemical impurity associated with the synthesis of Metoprolol hydrochloride, a selective beta-1 adrenergic blocker. This impurity is relevant for pharmaceutical quality control and analytical studies, aiding in the purification and characterization of active pharmaceutical ingredients. Its presence may impact the safety and efficacy profiles of drug formulations, making it essential for compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Vonoprazan impurity 4 is a structural derivative of Vonoprazan, primarily classified as a drug impurity. It is utilized in the analytical study and quality control of pharmaceutical formulations containing Vonoprazan. This compound aids in understanding the stability and purity of the drug, ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Pantoprazole impurity 43 is a substance related to Pantoprazole, primarily identified as a drug impurity. This compound is utilized in the research of pharmaceutical formulations and quality control assessments, aiding in the identification and characterization of impurities in drug development processes. Its analysis is crucial for ensuring the safety and efficacy of Pantoprazole-based therapies. -
Oseltamivir Impurity
Ethyl 4-acetamido-3-hydroxybenzoate is a known impurity of Oseltamivir, an antiviral medication effective against influenza viruses. This compound is utilized in the assessment of Oseltamivir purity and stability during pharmaceutical development and quality control processes. Its precise characterization aids researchers in understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Brexpiprazole impurity 1 is a chemical impurity related to the atypical antipsychotic Brexpiprazole, which primarily targets serotonin and dopamine receptors. This impurity can be utilized in the assessment of drug quality and to investigate the stability and degradation pathways of Brexpiprazole. Its presence may influence the pharmacological profile and safety evaluations in related research applications. -
Drug Impurity
Enzalutamide impurity 4 is a recognized impurity associated with Enzalutamide, a potent androgen receptor inhibitor. This compound is essential for analytical research, particularly in assessing the purity and stability of Enzalutamide formulations. It serves as a valuable tool in drug development and quality control processes, facilitating the identification and quantification of impurities in pharmaceutical applications. -
Drug Impurity
Glimepiride impurity 1 is identified as a chemical impurity associated with the antidiabetic agent Glimepiride. It is critical for quality control and characterization in pharmaceutical research, particularly in the development and validation of analytical methods for Glimepiride formulations. This impurity aids in the assessment of drug purity and stability, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
5-Nitrobenzofuran is identified as a drug impurity with potential relevance in pharmaceutical research. It may be generated during the synthesis of certain drug compounds and can influence the efficacy and safety profiles of these pharmaceuticals. Understanding its properties and behavior is crucial for the optimization of drug formulation and quality control in the development of therapeutic agents. -
Drug Impurity
Apixaban impurity 10 is a chemical byproduct associated with the synthesis of Apixaban, an oral anticoagulant that selectively inhibits factor Xa. This impurity is essential for quality control and analytical studies to ensure the purity and efficacy of Apixaban formulations. Research applications include utilization in method development, validation processes, and stability studies within pharmaceutical research. -
Drug Impurity
Buspirone impurity 9 is identified as an impurity of the anxiolytic compound Buspirone. This chemical can be utilized in research focused on drug purity and formulation, serving as a reference standard for analytical testing. Its characterization is essential for understanding the pharmacological profiles and safety assessments of Buspirone-related products in pharmaceutical development. -
Drug Impurity
Ticagrelor impurity 5 is a chemical impurity associated with the antiplatelet medication Ticagrelor, primarily targeting the P2Y12 receptor. This reagent is crucial for the analysis of drug purity and quality control in pharmaceutical research. Its identification and quantification can aid in the assessment of synthetic processes and help ensure the safety and efficacy of Ticagrelor formulations. -
Drug Impurity
Afatinib impurity 5 is a chemical impurity associated with the tyrosine kinase inhibitor Afatinib, which primarily targets EGFR and HER2 pathways. This impurity can be utilized in quality control and characterization studies for drug development, ensuring the purity and efficacy of pharmaceutical formulations. Detailed analysis of impurity profiles, such as Afatinib impurity 5, is crucial for compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Afatinib impurity 1 (also known as Afatinib Impurity CSEJXA) is a chemical impurity associated with the drug Afatinib, which functions as an irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity is essential for the characterization and quality control of Afatinib in pharmaceutical development and can be utilized in research focusing on EGFR-targeted therapies. Understanding the profile of Afatinib impurity 1 helps ensure the integrity and safety of EGFR-inhibiting compounds in various biological applications. -
Aspartame Impurity
Cyclo(Phe-Asp) is a cyclic dipeptide that serves as an impurity associated with Aspartame. This compound is utilized in chemical research to study the structural characteristics and purity of Aspartame formulations. Its presence can affect the overall quality and efficacy of Aspartame in various applications, making it an important marker in analytical studies of artificial sweeteners and related compounds. -
Drug Impurity
Donepezil impurity 15 is a chemical impurity associated with Donepezil, a reversible inhibitor of acetylcholinesterase. This impurity can serve as a reference standard in analytical and quality control laboratories for the characterization of Donepezil formulations. Research applications include stability testing, impurity profile assessments, and compliance with regulatory requirements in drug development. -
Drug Impurity
cis-4-[Bis(phenylmethyl)amino]cyclohexanemethanol is characterized as a drug impurity. This compound may be utilized in studies examining the safety and efficacy of pharmaceuticals by promoting a better understanding of impurity profiles. Its relevance spans analytical methods in drug development and quality control assessments, providing insights into the pharmacological implications of related compounds. -
Drug Impurity
Ramelteon impurity 10 is a known impurity of the sleep-aid compound Ramelteon, which primarily acts as a melatonin receptor agonist. This reagent is crucial for analyzing the purity of Ramelteon formulations in pharmaceutical research and quality control. Its presence can influence pharmacological outcomes and stability studies, making it essential for thorough characterizations in drug development.
